Oral Presentations Abstracts: FOUNDATIONAL ELEMENTS OF AN ETHICAL DECISION-MAKING MODEL APPLIED IN THE BIOPHARMACEUTICAL CONTEXT

Claar VAN DER ZEE; Tatjana POPLAZAROVA; Veronique DELPIRE

doi:10.24193/subbbioethica.2021.spiss.122

Oral Presentations Abstracts: FOUNDATIONAL ELEMENTS OF AN ETHICAL DECISION-MAKING MODEL APPLIED IN THE BIOPHARMACEUTICAL CONTEXT

Authors

Claar VAN DER ZEE PhD, GSK Vaccines, Wavre, Belgium. E-mail: clara.x.van-der-zee@gsk.com
Tatjana POPLAZAROVA MSc and MA, GSK Vaccines, Wavre, Belgium. E-mail: tatjana.poplazarova@gsk.com
Veronique DELPIRE Words and Science, Brussels, Belgium

DOI:

https://doi.org/10.24193/subbbioethica.2021.spiss.122

Abstract

View of Volume 66, Special Issue, September 2021

We previously described an applied values-based decision-making model and reported on its use in biopharmaceutical research and development (R&D)*. The model, known by the acronym “TRIP &TIPP”, uses company values along with framing questions as part of a five-step process to guide decisions to complex questions. The employees are engaged as moral agents applying values and principles. Their moral intuition is guided by systematic use of explicit framing questions to increase the understanding and clarity of the values and contextual questions to facilitate the practical implementation of solutions. Sometimes these solutions lead to the creation of internal guidelines in the company.

STUDIA UBB BIOETHICA, Volume 66 (LXVI), Special Issue, 2021

Published

2021-09-15

How to Cite

VAN DER ZEE, C., POPLAZAROVA, T., & DELPIRE, V. (2021). Oral Presentations Abstracts: FOUNDATIONAL ELEMENTS OF AN ETHICAL DECISION-MAKING MODEL APPLIED IN THE BIOPHARMACEUTICAL CONTEXT. Studia Universitatis Babeș-Bolyai Bioethica, 66(Special Issue), 178–179. https://doi.org/10.24193/subbbioethica.2021.spiss.122